Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?

por jcdadm.website | maio 31, 2018 | Publication

Gauthier S, Zhang H, Ng KP, Pascoal TA, Rosa-Neto P. Transl Neurodegener. 2018 May 31;7:12. doi: 10.1186/s40035-018-0117-9. eCollection 2018.

Anosognosia predicts default mode network hypometabolism and clinical progression to dementia.

por jcdadm.website | mar 13, 2018 | Publication

Therriault J, Ng KP, Pascoal TA, Mathotaarachchi S, Kang MS, Struyfs H, Shin M, Benedet AL, Walpola IC, Nair V, Gauthier S, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative. Neurology. 2018 Mar 13;90(11):e932-e939. doi: 10.1212/WNL.0000000000005120. Epub...

CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem.

por jcdadm.website | jan 30, 2018 | Publication

Benedet AL, Yu L, Labbe A, Mathotaarachchi S, Pascoal TA, Shin M, Kang MS, Gauthier S, Rouleau GA, Poirier J, Bennett DA, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative. Neurol Genet. 2018 Jan 30;4(1):e216. doi: 10.1212/NXG.0000000000000216....

Targeting Alzheimer’s Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.

por jcdadm.website | jan 1, 2018 | Publication

Gauthier S, Ng KP, Pascoal TA, Zhang H, Rosa-Neto P. J Alzheimers Dis. 2018;64(s1):S23-S31. doi: 10.3233/JAD-179924.

Identifying incipient dementia individuals using machine learning and amyloid imaging.

por jcdadm.website | nov 1, 2017 | Publication

Mathotaarachchi S, Pascoal TA, Shin M, Benedet AL, Kang MS, Beaudry T, Fonov VS, Gauthier S, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative. Neurobiol Aging. 2017 Nov;59:80-90. doi: 10.1016/j.neurobiolaging.2017.06.027. Epub 2017 Jul 11.